Clinical Trials
4 trialsNCT02654340 2023-02-10
TuScCom
CENTOGENE GmbH Rostock
Terminated
NCT03525834 2021-09-09
Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.
Novartis
Phase 4 Completed
NCT01059318 2020-11-19
A Study to Determine the Safety and Effectiveness of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis
Novartis
Phase 2 Completed
NCT00790400 2017-02-17
EXIST-2
Novartis
Phase 3 Completed